NRC HEALTH
No SEC Form 4 filings for $NRC in the last 30 days.
See all $NRC insider activity →NRC Health (NRC) appointed CEO Trent Green as interim principal financial officer, effective October 14, 2026. Green previously held CEO and COO roles at Amazon One Medical and senior positions at Legacy Health. The reason for the change was not disclosed.
NRC HEALTH (NRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 14, 2026, the board of directors of NRC Health, a Delaware corporation (the "Company"), designated Trent Green,
NRC HEALTH (NRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corpor
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning NRC (NRC HEALTH). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent NRC coverage spans financial news, corporate actions and earnings.
Minor executive change with limited immediate market impact.
The appointment does not involve compensation changes and is unlikely to move the stock.
CFO turnover is a near-term governance and execution risk, but the filing provides no financial guidance or operational details.
The article frames a backlog step-up as a near-to-intermediate revenue and cash-flow tailwind for NRC Health.
The filing provides fresh operating and profitability datapoints (TRCV growth, revenue growth, adjusted profitability, and cash flow) plus a declared dividend.
AlphAI scores every news story that mentions NRC with an AI model for sentiment and relevance, and aggregates insider trades from NRC HEALTH's SEC EDGAR Form 4 filings. Figures refresh continuously.
NRC Health (NRC) appointed CEO Trent Green as interim principal financial officer, effective October 14, 2026. Green previously held CEO and COO roles at Amazon One Medical and senior positions at Legacy Health. The reason for the change was not disclosed.
1 min readNRC HEALTH (NRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 14, 2026, the board of directors of NRC Health, a Delaware corporation (the "Company"), designated Trent Green,
1 min readNRC HEALTH (NRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corpor
2 min readLong Cast Advisers’ Q2 2026 investor letter cites improved firm performance and highlights NRC Health (NASDAQ:NRC). The article says NRC Health closed Aug 7, 2026 at $20.34, with $449.9M market cap and 9.30% YTD gain. It notes a “largest contract” and record 12-month backlog, with deferred revenue rising and management expecting the contract’s second year to be larger.
4 min readNRC HEALTH (NRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_992998.htm EXHIBIT 99.1 ex_992998.htm Exhibit 99.1 1245 Q Street, Lincoln, NE 68508 P: 1 800 388 4264 | F: 402 475 9061 nrchealth.com NRC HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS Second quarter TRCV* increased 11% year-over-year to $151.9 million LINCOLN, Nebrask
4 min readNRC HEALTH (NRC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-3.2 3 ex_981880.htm EXHIBIT 3.2 ex_981880.htm Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF NRC HEALTH (a Delaware corporation) As amended through June 24, 2026 ARTICLE I. OFFICES 1.01. Principal and Business Offices. The Corporation may have such principal and other busin
3 min readCitizens JMP initiated coverage of National Research (NASDAQ:NRC) with a “mkt outperform” rating and a $23.00 price target, implying 22.1% upside from $18.84. Separately, Weiss Ratings upgraded NRC to “hold (c-)” from “sell (d+)” on May 29. NRC reported Q1 EPS of $0.21 on $34.8M revenue.
4 min readNational Research Corp. (NRC) is currently undervalued, trading at a modest multiple despite clear indicators of a shift from contraction to growth. Key metrics like TRCV show a strong year-over-year increase, signaling upcoming revenue acceleration and a positive outlook for 2026. With expanding margins, potential normalized free cash flow approaching $38M, and a revitalized sales force, NRC is positioned for significant upside, potentially reaching $30+ per share.
4 min readNRC Health's Q3 earnings are impacted by rising interest expenses, but margin gains, cash flow strength and a 33% dividend hike offset these headwinds.
3 min readThe project launch event, held at the Vertolaye site, brought together State officials, elected representatives, and several project partners to accelerate pharmaceutical innovation in Europe ...
3 min read
